Case of an anti ‐NMDA receptor encephalitis patient responding to cyclophosphamide with significant brain volume recovery

Conclusions] CPM should be considered for non‐responders to first‐line immunotherapy.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Tags: CASE REPORT Source Type: research